Structure, function, and regulation of carboxylesterases

Toxicology of Organophosphate & Carbamate Compounds

Volumn , Issue , 2006, Pages 219-231

  Hosokawa, Masakiyo ^a   Satoh, Tetsuo ^b,c  

^a CHIBA INSTITUTE OF SCIENCE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c HAB Research Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67349260983     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088523-7/50017-X     Document Type: Chapter

References (56)

1. Aida K., Moore R., Negishi M. Cloning and nucleotide sequence of a novel, male-predominant carboxylesterase in mouse liver. Biochim. Biophys. Acta 1993, 1174:72-74.
2. Alam M., Vance D.E., Lehner R. Structure-function analysis of human triacylglycerol hydrolase by site-directed mutagenesis: Identification of the catalytic triad and a glycosylation site. Biochemistry 2002, 41:6679-6687.
3. Aldridge W.N. The esterases: Perspectives and problems. Chem.-Biol. Interact. 1993, 87:5-13.
4. Bencharit S., Morton C.L., Howard-Williams E.L., Danks M.K., Potter P.M., Redinbo M.R. Structural insights into CPT-11 activation by mammalian carboxylesterases. Nat. Struct. Biol. 2002, 9:337-342.
5. Bencharit S., Morton C.L., Hyatt J.L., Kuhn P., Danks M.K., Potter P.M., Redinbo M.R. Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: From binding promiscuity to selective inhibition. Chem. Biol. 2003, 10:341-349.
6. Bencharit S., Morton C.L., Xue Y., Potter P.M., Redinbo M.R. Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. Nat. Struct. Biol. 2003, 10:349-356.
7. Cygler M., Schrag J.D., Sussman J.L., Harel M., Silman I., Gentry M.K., Doctor B.P. Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related proteins. Protein Sci. 1993, 2:366-382.
8. Dolinsky V.W., Sipione S., Lehner R., Vance D.E. The cloning and expression of a murine triacylglycerol hydrolase cDNA and the structure of its corresponding gene. Biochim. Biophys. Acta 2001, 1532:162-172.
9. Frey P.A., Whitt S.A., Tobin J.B. A low-barrier hydrogen bond in the catalytic triad of serine proteases. Science 1994, 264:1927-1930.
10. Furihata T., Hosokawa M., Nakata F., Satoh T., Chiba K. Purification, molecular cloning, and functional expression of inducible liver acylcarnitine hydrolase in C57BL/6 mouse, belonging to the carboxylesterase multigene family. Arch. Biochem. Biophys. 2003, 416:101-109.
11. Furihata T., Hosokawa M., Koyano N., Nakamura T., Satoh T., Chiba K. Identification of di-(2-ethylhexyl) phthalate-induced carboxylesterase 1 in C57BL/6 mouse liver microsomes: Purification, cDNA cloning, and baculovirus-mediated expression. Identification of the cytosolic carboxylesterase catalyzing the 5'-deoxy-5-fluorocytidine formation from capecitabine in human liver. Drug Metab. Dispos. 2004, 32:1170-1177.
12. Furihata T., Hosokawa M., Satoh T., Chiba K. Synergistic role of specificity proteins and upstream stimulatory factor 1 in transactivation of the mouse carboxylesterase 2/microsomal acylcarnitine hydrolase gene promoter. Biochem. J. 2004, 384:101-110.
13. Furihata T., Hosokawa M., Fujii A., Derbel M., Satoh T., Chiba K. Dexamethasone-induced methylprednisolone hemisuccinate hydrolase: Its identification as a member of the rat carboxylesterase 2 family and its unique existence in plasma. Biochem. Pharmacol. 2005, in press.
14. Hattori K., Igarashi M., Itoh M., Tomisawa H., Ozawa N., Tateishi M. Purification and characterization of glucocorticoid-inducible steroid esterase in rat hepatic microsomes. Specific induction by glucocorticoids of steroid esterase in rat hepatic microsomes and its release into serum. Biochem. Pharmacol. 1992, 43:1929-1937.
15. Hosokawa M., Maki T., Satoh T. Multiplicity and regulation of hepatic microsomal carboxylesterases in rats. Mol. Pharmacol. 1987, 31:579-584.
16. Hosokawa M., Maki T., Satoh T. Differences in the induction of carboxylesterase isozymes in rat liver microsomes by xenobiotics. Biochem. Pharmacol. 1988, 37:2708-2711.
17. Hosokawa M., Maki T., Satoh T. Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans. Arch. Biochem. Biophys. 1990, 277:219-227.
18. Hosokawa M., Hirata K., Nakata F., Suga T., Satoh T. Species differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl)phthalate, a peroxisome proliferator. Drug Metab. Dispos. 1994, 22:889-894.
19. Howarth J.A., Price S.C., Dobrota M., Kentish P.A., Hinton R.H. Effects on male rats of di-(2-ethylhexyl) phthalate and di-n-hexylphthalate administered alone or in combination. Toxicol. Lett. 2001, 121:35-43.
20. Imai T., Yoshigae Y., Hosokawa M., Chiba K., Otagiri M. Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration. J. Pharmacol. Exp. Ther. 2003, 307:1234-1242.
21. Inoue M., Morikawa M., Tsuboi M., Sugiura M. Species difference and characterization of intestinal esterase on the hydrolizing activity of ester-type drugs. Jpn. J. Pharmacol. 1979, 29:9-16.
22. Kamendulis L.M., Brzezinski M.R., Pindel E.V., Bosron W.F., Dean R.A. Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases. J. Pharmacol. Exp. Ther. 1996, 279:713-717.
23. Korza G., Ozols J. Complete covalent structure of 60-kDa esterase isolated from 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced rabbit liver. J. Biol. Chem. 1988, 263:3486-3495.
24. Kroetz D.L., McBride O.W., Gonzalez F.J. Glycosylation-dependent activity of baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms. Biochemistry 1993, 32:11606-11617.
25. Kusano K., Seko T., Tanaka S., Shikata Y., Ando T., Ida S., Hosokawa M., Satoh T., Yuzuriha T., Horie T. Purification and characterization of monkey liver amidohydrolases and its relationship to a metabolic polymorphism of E6123, a platelet activating factor receptor antagonist. Drug Metab. Dispos. 1996, in press.
26. Langmann T., Becker A., Aslanidis C., Notka F., Ullrich H., Schwer H., Schmitz G. Structural organization and characterization of the promoter region of a human carboxylesterase gene. Biochim. Biophys. Acta 1997, 1350:65-74.
27. Maki T., Hosokawa M., Satoh T., Sato K. Changes in carboxylesterase isoenzymes of rat liver microsomes during hepatocarcinogenesis. Jpn. J. Cancer Res. 1991, 82:800-806.
28. Medda S., Takeuchi K., Devore-Carter D., von Deimling O., Heymann E., Swank R.T. An accessory protein identical to mouse egasyn is complexed with rat microsomal beta-glucuronidase and is identical to rat esterase-3. J. Biol. Chem. 1987, 262:7248-7253.
29. Mentlein R., Suttorp M., Heymann E. Specificity of purified monoacylglycerol lipase, palmitoyl-CoA hydrolase, palmitoyl-carnitine hydrolase, and nonspecific carboxylesterase from rat liver microsomes. Arch. Biochem. Biophys. 1984, 228:230-246.
30. Mori M., Hosokawa M., Ogasawara Y., Tsukada E., Chiba K. cDNA cloning, characterization and stable expression of novel human brain carboxylesterase. FEBS Lett. 1999, 458:17-22.
31. Ohtsuka K., Inoue S., Kameyama M., Kanetoshi A., Fujimoto T., Takaoka K., Araya Y., Shida A. Intracellular conversion of irinotecan to its active form, SN-38, by native carboxylesterase in human non-small cell lung cancer. Lung Cancer 2003, 41:187-198.
32. Ovnic M., Swank R.T., Fletcher C., Zhen L., Novak E.K., Baumann H., Heintz N., Ganschow R.E. Characterization and functional expression of a cDNA encoding egasyn (esterase-22): The endoplasmic reticulum-targeting protein of beta-glucuronidase. Genomics 1991, 11:956-967.
33. Ovnic M., Tepperman K., Medda S., Elliott R.W., Stephenson D.A., Grant S.G., Ganschow R.E. Characterization of a murine cDNA encoding a member of the carboxylesterase multigene family. Genomics 1991, 9:344-354.
34. Ozols J. Isolation, properties, and the complete amino acid sequence of a second form of 60-kDa glycoprotein esterase. J. Biol. Chem. 1989, 264:12533-12545.
35. Pelham H.R. The retention signal for soluble proteins of the endoplasmic reticulum. Trends Biochem. Sci. 1990, 15:483-486.
36. Pindel E.V., Kedishvili N.Y., Abraham T.L., Brzezinski M.R., Zhang J., Dean R.A., Bosron W.F. Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J. Biol. Chem. 1997, 272:14769-14775.
37. Prueksaritanont T., Gorham L.M., Hochman J.H., Tran L.O., Vyas K.P. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metab. Dispos. 1996, 24:634-642.
38. Robbi M., Beaufay H. Cloning and sequencing of rat liver carboxylesterase ES-3 (egasyn). Biochem. Biophys. Res. Commun. 1994, 203:1404-1411.
39. Robbi M., Beaufay H., Octave J.N. Nucleotide sequence of cDNA coding for rat liver pI 6.1 esterase (ES-10), a carboxylesterase located in the lumen of the endoplasmic reticulum. Biochem. J. 1990, 269:451-458.
40. Sanghani S.P., Quinney S.K., Fredenburg T.B., Sun Z., Davis W.I., Murry D.J., Cummings O.W., Seitz D.E., Bosron W.F. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. Clin. Cancer Res. 2003, 9:4983-4991.
41. Satoh T., Hosokawa M. The mammalian carboxylesterases: From molecules to functions. Annu. Rev. Pharmacol. Toxicol. 1998, 38:257-288.
42. Satoh T., Hosokawa M., Atsumi R., Suzuki W., Hakusui H., Nagai E. Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase. Biol. Pharm. Bull. 1994, 17:662-664.
43. Satoh T., Taylor P., Bosron W.F., Sanghani S.P., Hosokawa M., La Du B.N. Current progress on esterases: From molecular structure to function. Drug Metab. Dispos. 2002, 30:488-493.
44. Shibata F., Takagi Y., Kitajima M., Kuroda T., Omura T. Molecular cloning and characterization of a human carboxylesterase gene. Genomics 1993, 17:76-82.
45. Tabata T., Katoh M., Tokudome S., Nakajima M., Yokoi T. Identification of the cytosolic carboxylesterase catalyzing the 5'-deoxy-5-fluorocytidine formation from capecitabine in human liver. Drug Metab. Dispos. 2004, 32:1103-1110.
46. Takai S., Matsuda A., Usami Y., Adachi T., Sugiyama T., Katagiri Y., Tatematsu M., Hirano K. Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. Biol. Pharm. Bull. 1997, 20:869-873.
47. Takayama H., Watanabe A., Hosokawa M., Chiba K., Satoh T., Aimi N. Synthesis of a new class of camptothecin derivatives, the long-chain fatty acid esters of 10-hydroxy-camptothecin, as a potent prodrug candidate, and their in vitro metabolic conversion by carboxylesterases. Bioorg. Med. Chem. Lett. 1998, 8:415-418.
48. Tang B.K., Kalow W. Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver. 4. Eur. J. Clin. Pharmacol. 1995, 47:449-451.
49. von Heijne G. Patterns of amino acids near signal-sequence cleavage sites. Eur. J. Biochem. 1983, 133:17-21.
50. Wallace T.J., Ghosh S., McLean Grogan W. Molecular cloning and expression of rat lung carboxylesterase and its potential role in the detoxification of organophosphorus compounds. Am. J. Respir. Cell. Mol. Biol. 1999, 20:1201-1208.
51. Watanabe K., Kayano Y., Matsunaga T., Yamamoto I., Yoshimura H. Purification and characterization of a novel 46.5-kilodalton esterase from mouse hepatic microsomes. Biochem. Mol. Biol. Int. 1993, 31:25-30.
52. Wong H., Schotz M.C. The lipase gene family. J. Lipid Res. 2002, 43:993-999.
53. Xie M., Yang D., Wu M., Xue B., Yan B. Mouse liver and kidney carboxylesterase (M-LK) rapidly hydrolyzes antitumor prodrug irinotecan and the N-terminal three quarter sequence determines substrate selectivity. Drug Metab. Dispos. 2003, 31:21-27.
54. Zhang J., Burnell J.C., Dumaual N., Bosron W.F. Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. J. Pharmacol. Exp. Ther. 1999, 290:314-318.
55. Zhu W., Song L., Zhang H., Matoney L., LeCluyse E., Yan B. Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats. Drug Metab. Dispos. 2000, 28:186-191.
56. Zschunke F., Salmassi A., Kreipe H., Buck F., Parwaresch M.R., Radzun H.J. cDNA cloning and characterization of human monocyte/macrophage serine esterase-1. Blood 1991, 78:506-512.